Wednesday, September 2, 2015

Amgen to Help Develop Novartis's Pipeline of Alzheimer's Drugs

Novartis AG will share the risks and rewards as Amgen Inc. will help develop its pipeline of experimental Alzheimer’s disease drugs.

from WSJ.com: US Business http://ift.tt/1FiZ10i
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)